Rhythmia Medical, Inc. is a prominent player in the Biotechnology, Health Care, and Manufacturing industries. Founded in 2004 by Doron Harlev and Leon Amariglio, the company developed a cutting-edge 3D mapping and navigation platform for EP - the treatment of cardiac arrhythmias. Backed by venture capital, it secured a significant $5.00M investment in its last funding round on 24 September 2010. In 2012, the company was successfully acquired by Boston Scientific, marking a significant milestone for both the company and its investors. Operating from the United States, Rhythmia Medical's innovative approach to cardiac care made it an attractive prospect for investment and acquisition. This strategic move by Boston Scientific highlights the potential for lucrative returns in the rapidly expanding health technology sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | $5.00M | - | 24 Sep 2010 | |
| Venture Round | $2.70M | - | 18 Mar 2010 | |
| Grant | $200.00K | 1 | National Institutes of Health | 01 Mar 2009 |
| Series B | $7.00M | 1 |
|
06 Feb 2007 |
| Series A | $1.90M | - | 16 Aug 2005 |
No recent news or press coverage available for Rhythmia Medical, Inc..
We care about your data, and we'd love to use cookies make your experience better.
